ArticleProceedings of the National Academy of Sciences of the United States of America1997

A lymphocyte-activating monoclonal antibody induces regression of human tumors in severe combined immunodeficient mice.

B Hardy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.